Option Care(US:OPCH)2026-01-12 21:31Financial Projections - Net revenue for Q4 2025 is expected to be between $1.46 billion and $1.47 billion, with full year 2025 net revenue projected between $5.645 billion and $5.655 billion[3]. - GAAP net income for Q4 2025 is anticipated to be between $59.1 million and $62.4 million, while full year 2025 GAAP net income is expected to range from $208.2 million to $211.5 million[3]. - Adjusted diluted EPS for Q4 2025 is projected to be between $0.46 and $0.49, and for full year 2025, it is expected to be between $1.72 and $1.76[3]. - Adjusted EBITDA for Q4 2025 is expected to be between $123.7 million and $127.7 million, while for full year 2025, it is projected to be between $469.0 million and $473.0 million[3]. - Cash flow from operations is expected to be below $320 million for full year 2025[3]. - Preliminary financial guidance for full year 2026 includes net revenue expected to be between $5.8 billion and $6.0 billion, with adjusted diluted EPS projected between $1.82 and $1.92[3]. Share Repurchase Program - The company has expanded its share repurchase program authorization from $500 million to $1.0 billion, with approximately $95 million repurchased in Q4 2025 and $307 million for the full year 2025[4][5]. Future Events - The company will provide further details on its full year 2026 financial guidance during the fourth quarter earnings call in February[2]. - The company is participating in the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026, to present its financial outlook[6]. Financial Data Disclaimer - The preliminary financial data is subject to completion of year-end close procedures and may change before finalization[12].